Brunnur Ventures GP — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Axelyfaxelyf.cominJul 2025✓ verified
Axelyf develops RNA medicines built on nanotechnology formulations and nucleic acid technologies, working across the drug development pathway from CMC and clinical pharmacology to computational sciences.
AI & Machine LearningBiotechDeep TechHealthtechChestnut Hill, US
Orn Almarsson(Executive Officer, Director, Promoter)
BoardArni Blondal(Director)John Lucas(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.